A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Clinical trial NCT05144854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05144854
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2025-10-20
- Enrollment
- 626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.